Table 3.
Comparison of test outcomes from MP (High/Low Risk) between NGS assessed at Agendia Amsterdam central laboratory and NGS assessed at the beta sites (n = 114∗). These results show a Negative Predictive Agreement (Low Risk) of 98.3% (58/59, 95% CI: 91.0–99.7), a Positive Predictive Agreement (High Risk) of 89.1% (49/55, 95% CI: 78.2–94.9), a concordance of 93.9% and a Cohen's kappa of 0.88.
NGS Agendia |
||||
---|---|---|---|---|
High Risk | Low Risk | Total | ||
NGS Beta Sites | High Risk | 49 | 1 | 50 |
Low Risk | 6 | 58 | 64 | |
Total | 55 | 59 | 114∗ |
For 10 samples, no NGS results were obtained at Agendia.